Specialty
Specialty spend continues to grow rapidly; CVS Health continues to innovate with strategies that reduced the trend impact of inflation significantly, to 1.7 percent. More
Video
“High-Cost Drugs”
49 result(s)
Drug Pipeline
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage the pipeline More
Feature
Cost Management
Dynamic forces are affecting health and pharmacy care, affordability, and access. CVS Health is aligning efforts to address these challenges with More
Video
Cost Management
As a health care innovation company, our steadfast focus is on helping to reduce costs and improve outcomes for our pharmacy benefit management (PBM) clients and their plan... More
Feature
Cost Management
A Guaranteed Net Cost model can adapt to evolving market trends and help payors stay ahead of manufacturer strategies such as authorized generics, and changing legislative... More
Briefing
Drug Pipeline
Peanut allergy is the most common of childhood food allergies — and getting more common. Research presented at the annual meeting of the American College of Allergy, Asthma and... More
Feature
Cost Management
Epidiolex, the latest cannabis-based drug to be approved by the FDA to treat certain seizure disorders, is a highly potent form of cannabidiol. Given the narrow indication and... More
Feature
Cost Management
The Guaranteed Net Cost model guarantees average net spend per prescription, after discounts and rebates, for each distribution channel. More
Feature
Specialty
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Care Management
Oncologists need to take in an enormous amount of information to provide their patients with the most up-to-date treatment. CVS Specialty is partnering with NCCN to provide... More
Briefing